IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection

Infection and Immunity

Volumn 74, Issue 1, 2006, Pages 497-503

  Åkesson, Per ^a   Moritz, Linnea ^b   Truedsson, Mikael ^c   Christensson, Bertil ^a   Von Pawel Rammingen, Ulrich ^b  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CYSTEINE PROTEINASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G CLEAVING ENZYME IDES; IMMUNOGLOBULIN HEAVY CHAIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTEREMIA; BLOOD SAMPLING; CELL KILLING; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME RELEASE; ERYSIPELAS; HUMAN; IMMUNE RESPONSE; NONHUMAN; PHAGOCYTOSIS; PHARYNGITIS; PRIORITY JOURNAL; PROTEIN TARGETING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURVIVAL; TONSILLITIS;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTEREMIA; BACTERIAL PROTEINS; BASE SEQUENCE; BLOOD BACTERICIDAL ACTIVITY; CYSTEINE PROTEINASE INHIBITORS; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 29644438454     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.1.497-503.2006     Document Type: Article

References (26)

1. Agniswamy, J., B. Lei, J. M. Musser, and P. D. Sun. 2004. Insight of host immune evasion mediated by two variants of group A streptococcus Mac protein. J. Biol. Chem. 279:52789-52796.
2. Åkesson, P., A. Linder, J. Cronqvist, and B. Christensson. 2004. Group A Streptococcus bacteraemia complicated by osteomyelitis in an immunocompetent adult. Scand. J. Infect. Dis. 36:63-65.
3. Åkesson, P., M. Rasmussen, E. Mascini, U. von Pawel-Rammingen, R. Janulczyk, M. Collin, A. Olsén, E. Mattsson, M. L. Olsson, L. Björck, and B. Christensson. 2004. Low antibody titers to cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J. Infect. Dis. 189:797-804.
4. Basma, H., A. Norrby-Teglund, Y. Guedez, A. McGeer, D. E. Low, O. El-Ahmedy, B. Schwartz, and M. Kotb. 1999. Risk factors in the pathogenesis of invasive group A streptococcal infections; role of protective humoral immunity. Infect. Immun. 67:1871-1877.
5. Beall, B., R. Facklam, T. Hoenes, and B. Schwartz. 1997. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J. Clin. Microbiol. 35:1231-1235.
6. Bisno, A. L. 2001. Acute pharyngitis. N. Engl. J. Med. 344:205-211.
7. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
8. Facklam, R. F., D. R. Martin, M. Lovgren, D. R. Johnson, A. Efstratiou, T. A. Thompson, S. Gowan, P. Kriz, G. J. Tyrrell, E. Kaplan, and B. Beall. 2002. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin. Infect. Dis. 34:28-38.
9. Gilbert, J. V., A. G. Plaut, B. Longmaid, and M. E. Lamm. 1983. Inhibition of microbial IgA proteases by human secretory IgA and serum. Mol. Immunol. 20:1039-1049.
10. Holm, S. E., A. Norrby, A. M. Bergholm, and M. Norgren. 1992. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J. Infect. Dis. 166:31-37.
11. Kawabata, S., Y. Tamura, J. Murakami, Y. Terao, I. Nakagawa, and S. Hamada. 2002. A novel, anchorless streptococcal surface protein that binds to human immunoglobulins. Biochem. Biophys. Res. Commun. 296:1329-1333.
12. Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.
13. Lei, B., F. R. DeLeo, S. D. Reid, J. M. Voyich, L. Magoun, M. Liu, K. R. Braughton, S. Ricklefs, N. P. Hoe, R. L. Cole, J. M. Leong, and J. M. Musser. 2002. Opsonophagocytosis-inhibiting Mac protein of group A streptococcus: identification and characteristics of two genetic complexes. Infect. Immun 70:6880-6890.
14. Mascini, E. M., M. Jansze, J. F. Schellekens, J. M. Musser, J. A. Faber, L. A. Verhoef-Verhage, L. Schouls, W. J. van Leeuwen, J. Verhoef, and H. van Dijk. 2000. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin antibodies. J. Infect. Dis. 181:631-638.
15. Norrby-Teglund, A., K. Pauksens, S. E. Holm, and M. Norgren. 1994. Relation between low capacity of human serum to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect. Dis. 170:585-591.
16. Norrby-Teglund, A., R. Kaul, D. E. Low, A. McGeer, J. Andersson, U. Andersson, and M. Kotb. 1996. Evidence for the presence of streptococcal- superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect. Immun. 64:5395-5398.
17. Shet, A., E. L. Kaplan, D. R. Johnson, and P. P. Cleary. 2003. Immune response to group A streptococcal C5A peptidase in children: implications for vaccine development. J. Infect. Dis. 188:809-817.
18. Sriprakash, K. S., J. Hartas, and A. White. 2002. Antibodies to streptococcal inhibitor of complement function and M peptides in a post-streptococcal glomenilonephritis endemic region of Australia. J. Med. Microbiol. 51:589-594.
19. Stolz, S. J., J. P. Davis, J. M. Vergeront, B. A. Crass, P. J. Chesney, P. J. Wand, and M. S. Bergdoll. 1985. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J. Infect. Dis. 151:883-889.
20. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
21. Tyrrell, G. J., M. Lovgren, B. Forwick, N. P. Hoe, J. M. Musser, and J. A. Talbot. 2002. M types of group A streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J. Clin. Microbiol. 40:4466-4471.
22. Vincents, B., U. von Pawel-Rammingen, L. Björck, and M. Abrahamson. 2004. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 43:15540-15549.
23. von Pawel-Rammingen, U., B. P. Johansson, and L. Björck. 2002. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21:1607-1615.
24. von Pawel-Rammingen, U., B. P. Johansson, H. Tapper, and L. Björck. 2002. Streptococcus pyogenes and phagocytic killing. Nat. Med. 8:1044-1045.
25. Wenig, K., L. Chatwell, U. von Pawel-Rammingen, L. Björck, R. Huber, and P. Sondermann. 2004. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc. Natl. Acad. Sci. USA 101:17371-17376.
26. The Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390-391.